Xprost Eye Drop contains Travoprost 40 mcg/ml, a prostaglandin analog indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. Travoprost acts by increasing the outflow of aqueous humor through the uveoscleral pathway, thereby effectively lowering IOP. This medication is typically administered once daily in the affected eye(s), preferably in the evening, to maximize therapeutic efficacy. Xprost Eye Drop is contraindicated in patients with hypersensitivity to Travoprost or any of its excipients. Common adverse effects may include ocular hyperemia, eye irritation, eyelash changes, and increased pigmentation of the iris or periocular skin. Patients should be advised to avoid contaminating the dropper tip and to remove contact lenses prior to administration, reinserting them after 15 minutes. Regular monitoring of intraocular pressure is recommended to assess treatment response and adjust therapy accordingly. Use during pregnancy and lactation should be considered only if the potential benefit justifies the potential risk to the fetus or infant. Xprost Eye Drop should be stored at controlled room temperature, protected from light, and kept out of reach of children. Proper adherence to prescribed dosing is essential for optimal management of glaucoma and prevention of vision loss.